Type II-C CRISPR-Cas9 Biology, Mechanism, and Application
- PMID: 29202216
- PMCID: PMC5815938
- DOI: 10.1021/acschembio.7b00855
Type II-C CRISPR-Cas9 Biology, Mechanism, and Application
Abstract
Genome editing technologies have been revolutionized by the discovery of prokaryotic RNA-guided defense system called CRISPR-Cas. Cas9, a single effector protein found in type II CRISPR systems, has been at the heart of this genome editing revolution. Nearly half of the Cas9s discovered so far belong to the type II-C subtype but have not been explored extensively. Type II-C CRISPR-Cas systems are the simplest of the type II systems, employing only three Cas proteins. Cas9s are central players in type II-C systems since they function in multiple steps of the CRISPR pathway, including adaptation and interference. Type II-C CRISPR systems are found in bacteria and archaea from very diverse environments, resulting in Cas9s with unique and potentially useful properties. Certain type II-C Cas9s possess unusually long PAMs, function in unique conditions (e.g., elevated temperature), and tend to be smaller in size. Here, we review the biology, mechanism, and applications of the type II-C CRISPR systems with particular emphasis on their Cas9s.
Conflict of interest statement
The authors declare the following competing financial interest(s): E.J.S. is a co-founder and scientific advisor of Intellia Therapeutics. Northwestern University and the University of Massachusetts Medical School have patents pending for CRISPR technologies of which E.J.S. is an inventor.
Figures


Similar articles
-
Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications.ACS Chem Biol. 2018 Feb 16;13(2):347-356. doi: 10.1021/acschembio.7b00800. Epub 2017 Dec 5. ACS Chem Biol. 2018. PMID: 29121460 Free PMC article. Review.
-
Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.Mol Cell. 2017 Jul 6;67(1):117-127.e5. doi: 10.1016/j.molcel.2017.05.024. Epub 2017 Jun 9. Mol Cell. 2017. PMID: 28602637 Free PMC article.
-
The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.Mol Cell. 2017 Oct 5;68(1):15-25. doi: 10.1016/j.molcel.2017.09.007. Mol Cell. 2017. PMID: 28985502 Free PMC article. Review.
-
Fanzor is a eukaryotic programmable RNA-guided endonuclease.Nature. 2023 Aug;620(7974):660-668. doi: 10.1038/s41586-023-06356-2. Epub 2023 Jun 28. Nature. 2023. PMID: 37380027 Free PMC article.
-
A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.Chem Commun (Camb). 2018 Mar 7;54(19):2377-2380. doi: 10.1039/c7cc08893k. Epub 2018 Feb 16. Chem Commun (Camb). 2018. PMID: 29450416
Cited by
-
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6. J Adv Res. 2022. PMID: 36100328 Free PMC article. Review.
-
Expression and Functional Analysis of the Compact Thermophilic Anoxybacillus flavithermus Cas9 Nuclease.Int J Mol Sci. 2023 Dec 4;24(23):17121. doi: 10.3390/ijms242317121. Int J Mol Sci. 2023. PMID: 38069443 Free PMC article.
-
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy.Mol Cancer. 2022 Mar 3;21(1):64. doi: 10.1186/s12943-021-01487-4. Mol Cancer. 2022. PMID: 35241090 Free PMC article. Review.
-
An Update on the Application of CRISPR Technology in Clinical Practice.Mol Biotechnol. 2024 Feb;66(2):179-197. doi: 10.1007/s12033-023-00724-z. Epub 2023 Jun 3. Mol Biotechnol. 2024. PMID: 37269466 Free PMC article. Review.
-
Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease.Curr Pharm Des. 2025;31(8):598-618. doi: 10.2174/0113816128344571241018154506. Curr Pharm Des. 2025. PMID: 39492772 Review.
References
-
- Marraffini LA. CRISPR-Cas immunity in prokaryotes. Nature. 2015;526:55–61. - PubMed
-
- Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin EV, van der Oost J. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science. 2016;353:aad5147. - PubMed
-
- Barrangou R, Doudna JA. Applications of CRISPR technologies in research and beyond. Nature biotechnology. 2016;34:933–941. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources